Paul Alper points us to this article in Health News Review—I can’t figure out who wrote it—warning of problems with the use of surrogate outcomes for policy evaluation: “New drug improves bone density by 40%.” At first glance, this sounds like great news. But there’s a problem: We have no idea if this means the […] The post Problems with surrogate markers appeared fir